ArticleAnnals of translational medicine2016

PTK2/FAK: a new predictive biomarker for response to radiotherapy in head and neck squamous cell carcinoma.

Emma J de Ruiter et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.